Synovial sarcoma

WikiDoc Resources for Synovial sarcoma
Articles
Most recent articles on Synovial sarcoma Most cited articles on Synovial sarcoma Review articles on Synovial sarcoma Articles on Synovial sarcoma in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Synovial sarcoma Images of Synovial sarcoma Photos of Synovial sarcoma Podcasts & MP3s on Synovial sarcoma Videos on Synovial sarcoma
Evidence Based Medicine
Cochrane Collaboration on Synovial sarcoma Bandolier on Synovial sarcoma TRIP on Synovial sarcoma
Clinical Trials
Ongoing Trials on Synovial sarcoma at Clinical Trials.gov Trial results on Synovial sarcoma Clinical Trials on Synovial sarcoma at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Synovial sarcoma NICE Guidance on Synovial sarcoma NHS PRODIGY Guidance FDA on Synovial sarcoma CDC on Synovial sarcoma
Books
Books on Synovial sarcoma
News
Synovial sarcoma in the news Be alerted to news on Synovial sarcoma News trends on Synovial sarcoma
Commentary
Blogs on Synovial sarcoma
Definitions
Definitions of Synovial sarcoma
Patient Resources / Community
Patient resources on Synovial sarcoma Discussion groups on Synovial sarcoma Patient Handouts on Synovial sarcoma Directions to Hospitals Treating Synovial sarcoma Risk calculators and risk factors for Synovial sarcoma
Healthcare Provider Resources
Symptoms of Synovial sarcoma Causes & Risk Factors for Synovial sarcoma Diagnostic studies for Synovial sarcoma Treatment of Synovial sarcoma
Continuing Medical Education (CME)
CME Programs on Synovial sarcoma
International
Synovial sarcoma en Espanol Synovial sarcoma en Francais
Business
Synovial sarcoma in the Marketplace Patents on Synovial sarcoma
Experimental / Informatics
List of terms related to Synovial sarcoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Synonyms and keywords: Synonym 1; Synonym 2; Synonym 3

Historical Perspective

• Synovial sarcoma was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
• In [year], [gene] mutations were first identified in the pathogenesis of synovial sarcoma.
• In [year], the first [discovery] was developed by [scientist] to treat/diagnose synovial sarcoma.

Classification

• Synovial sarcoma may be classified according to [classification method] into [number] subtypes/groups:

• [group1]
• [group2]
• [group3]

• Other variants of synovial sarcoma include [disease subtype 1], [disease subtype 2], and [disease subtype 3].

Pathophysiology

• The pathogenesis of synovial sarcoma is characterized by [feature1], [feature2], and [feature3].
• The [gene name] gene/Mutation in [gene name] has been associated with the development of synovial sarcoma, involving the [molecular pathway] pathway.
• On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of synovial sarcoma.
• On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of synovial sarcoma.

Causes

• Synovial sarcoma may be caused by either [cause1], [cause2], or [cause3].
• Synovial sarcoma is caused by a mutation in the [gene1], [gene2], or [gene3] gene[s].
• There are no established causes for synovial sarcoma.

Differentiating synovial sarcoma from other Diseases

• Synovial sarcoma must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:

• [Differential dx1]
• [Differential dx2]
• [Differential dx3]

Epidemiology and Demographics

• The prevalence of synovial sarcoma is approximately [number or range] per 100,000 individuals worldwide.
• In [year], the incidence of synovial sarcoma was estimated to be [number or range] cases per 100,000 individuals in [location].

Age

• Patients of all age groups may develop synovial sarcoma.

• Synovial sarcoma is more commonly observed among patients aged [age range] years old.
• Synovial sarcoma is more commonly observed among [elderly patients/young patients/children].

Gender

• Synovial sarcoma affects men and women equally.

• [Gender 1] are more commonly affected with synovial sarcoma than [gender 2].
• The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.

Race

• There is no racial predilection for synovial sarcoma.

• Synovial sarcoma usually affects individuals of the [race 1] race.
• [Race 2] individuals are less likely to develop synovial sarcoma.

Risk Factors

• Common risk factors in the development of synovial sarcoma are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Natural History, Complications and Prognosis

• The majority of patients with synovial sarcoma remain asymptomatic for [duration/years].
• Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
• If left untreated, [#%] of patients with synovial sarcoma may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
• Common complications of synovial sarcoma include [complication 1], [complication 2], and [complication 3].
• Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with synovial sarcoma is approximately [#%].

Diagnosis

Diagnostic Criteria

• The diagnosis of synovial sarcoma is made when at least [number] of the following [number] diagnostic criteria are met:

• [criterion 1]
• [criterion 2]
• [criterion 3]
• [criterion 4]

Symptoms

• Synovial sarcoma is usually asymptomatic.
• Symptoms of synovial sarcoma may include the following:

• [symptom 1]
• [symptom 2]
• [symptom 3]
• [symptom 4]
• [symptom 5]
• [symptom 6]

Physical Examination

• Patients with synovial sarcoma usually appear [general appearance].
• Physical examination may be remarkable for:

• [finding 1]
• [finding 2]
• [finding 3]
• [finding 4]
• [finding 5]
• [finding 6]

Laboratory Findings

• There are no specific laboratory findings associated with synovial sarcoma.

• A [positive/negative] [test name] is diagnostic of synovial sarcoma.
• An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of synovial sarcoma.
• Other laboratory findings consistent with the diagnosis of synovial sarcoma include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings

• There are no [imaging study] findings associated with synovial sarcoma.

• [Imaging study 1] is the imaging modality of choice for synovial sarcoma.
• On [imaging study 1], synovial sarcoma is characterized by [finding 1], [finding 2], and [finding 3].
• [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

• Synovial sarcoma may also be diagnosed using [diagnostic study name].
• Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

• There is no treatment for synovial sarcoma; the mainstay of therapy is supportive care.

• The mainstay of therapy for synovial sarcoma is [medical therapy 1] and [medical therapy 2].
• [Medical therapy 1] acts by [mechanism of action1].
• Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

• Surgery is the mainstay of therapy for synovial sarcoma.
• [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of synovial sarcoma.
• [Surgical procedure] can only be performed for patients with [disease stage] synovial sarcoma.

Prevention

• There are no primary preventive measures available for synovial sarcoma.

• Effective measures for the primary prevention of synovial sarcoma include [measure1], [measure2], and [measure3].

• Once diagnosed and successfully treated, patients with synovial sarcoma are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].